Drugs / LUVAGROBART
last change Apr 2025 re-read 3 minutes ago

LUVAGROBART

also known as AK115

Monoclonal antibody targets NGF via inhibition

Investigated by
Akeso

Trials 1

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05286970 Mar → Sep 2022 — Akeso Completed No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as LUVAGROBART ChEMBL registry synonym — accepted as the source's own label CHEMBL5314849 ↗
Known as AK115 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05286970 ↗
Action Inhibit “anti-nerve growth factor” PMID 40297315 ↗ Apr 2025
Modality Monoclonal antibody “anti-nerve growth factor (NGF) monoclonal antibody” PMID 40297315 ↗ Apr 2025
Route Subcutaneous “Abdominal subcutaneous injection” NCT05286970 ↗
Target NGF “anti-nerve growth factor (NGF)” PMID 40297315 ↗ Apr 2025